[1]
M. K. Tuxen, S. Cold, U. B. Tange, E. Balslev, and D. L. Nielsen, “Phase II study of neoadjuvant pegylated liposomal doxorubicin and cyclophosphamide ± trastuzumab followed by docetaxel in locally advanced breast cancer”, AO, vol. 53, no. 10, pp. 1440–1445, Oct. 2014.